id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-V-0009-0001,FDA,FDA-1992-V-0009,Variance Approval from FDA CDRH to Jeff Cone Studios,Other,Approval for Variance (VRA),2002-12-31T05:00:00Z,2002,12,,,2015-09-25T18:13:35Z,,0,0,0900006480525e3b
FDA-2001-P-0214-0002,FDA,FDA-2001-P-0214,FDA/CDER to Veigh Hogan,Other,LET-Letter,2002-12-20T05:00:00Z,2002,12,,,2008-04-25T02:37:12Z,,0,0,09000064804e474d
FDA-2002-P-0251-0003,FDA,FDA-2002-P-0251,"FDA/CDER to PharmaForce, Inc.",Other,LET-Letter,2002-12-20T05:00:00Z,2002,12,,,2008-04-12T01:27:49Z,,0,0,090000648049bea0
FDA-2002-P-0077-0002,FDA,FDA-2002-P-0077,"FDA/CVM to Highland VetPharma, LLC.",Other,PAV-Petition Approval,2002-12-16T05:00:00Z,2002,12,,,2008-04-12T01:26:24Z,,0,0,090000648048d32f
FDA-2002-P-0170-0002,FDA,FDA-2002-P-0170,FDA/CVM to Intervet Inc.,Other,PAV-Petition Approval,2002-12-16T05:00:00Z,2002,12,,,2008-04-12T01:26:57Z,,0,0,09000064804949b6
FDA-2002-P-0297-0002,FDA,FDA-2002-P-0297,"FDA/CVM to Highland VetPharma, LLC",Other,PAV-Petition Approval,2002-12-16T05:00:00Z,2002,12,,,2008-04-12T01:28:08Z,,0,0,090000648049f202
FDA-2002-P-0005-0002,FDA,FDA-2002-P-0005,"FDA/CVM to Highland VetPharma, LLC",Other,PAV-Petition Approval,2002-12-16T05:00:00Z,2002,12,,,2008-04-12T01:25:47Z,,0,0,0900006480487280
FDA-2002-P-0129-0003,FDA,FDA-2002-P-0129,"FDA/CDER to Amarin Pharmaceuticals, Inc.",Other,PDN-Petition Denial,2002-12-06T05:00:00Z,2002,12,,,2008-04-12T01:26:43Z,,0,0,09000064804905e5
FDA-2002-P-0259-0002,FDA,FDA-2002-P-0259,FDA/CDER to Taro Research Institute Ltd.,Other,PAV-Petition Approval,2002-12-06T05:00:00Z,2002,12,,,2008-04-12T01:27:57Z,,0,0,090000648049c57d
FDA-2002-P-0166-0002,FDA,FDA-2002-P-0166,FDA/CDER to AAC Consulting Group,Other,PAV-Petition Approval,2002-12-06T05:00:00Z,2002,12,,,2008-04-12T01:26:53Z,,0,0,09000064804945df
FDA-2002-P-0173-0002,FDA,FDA-2002-P-0173,FDA/CDER to The Weinberg Group Inc.,Other,PAV-Petition Approval,2002-12-06T05:00:00Z,2002,12,,,2008-04-12T01:27:00Z,,0,0,0900006480494c28
FDA-1976-N-0027-0008,FDA,FDA-1976-N-0027,Letter from FDA/CDER to Bayer Corporation,Other,Letter(s),2002-11-27T05:00:00Z,2002,11,,,2015-10-29T19:49:11Z,,0,0,090000648051b762
FDA-2002-P-0164-0002,FDA,FDA-2002-P-0164,FDA/CDER to Covington & Burling - Petition Approval,Other,PAV-Petition Approval,2002-11-15T05:00:00Z,2002,11,,,2012-07-11T22:03:47Z,,0,0,090000648049444d
FDA-2002-P-0083-0002,FDA,FDA-2002-P-0083,"FDA/CVM to Phoenix Scientific, Inc.",Other,PAV-Petition Approval,2002-11-13T05:00:00Z,2002,11,,,2008-04-12T01:26:33Z,,0,0,090000648048da81
FDA-2002-P-0215-0002,FDA,FDA-2002-P-0215,"FDA/CDRH to Richdel, Inc.",Other,PAV-Petition Approval,2002-11-13T05:00:00Z,2002,11,,,2008-04-12T01:27:11Z,,0,0,0900006480496a8f
FDA-2002-P-0254-0002,FDA,FDA-2002-P-0254,"FDA/DDM to Pharmaceutical Solutions, Inc",Other,PAV-Petition Approval,2002-11-13T05:00:00Z,2002,11,,,2008-04-12T01:27:53Z,,0,0,090000648049c210
FDA-1993-V-0063-0001,FDA,FDA-1993-V-0063,Laser Display Associates Inc. - Approval for Variance,Other,VRA-Approval for Variance,2002-11-08T05:00:00Z,2002,11,,,2008-11-06T13:39:02Z,,0,0,09000064804fc98b
FDA-1993-V-0063-0002,FDA,FDA-1993-V-0063,Laser Display Associates Inc. - Approval for Variance,Other,VRA-Approval for Variance,2002-11-08T05:00:00Z,2002,11,,,2008-11-06T13:40:51Z,,0,0,09000064804fc99b
FDA-1993-V-0063-0004,FDA,FDA-1993-V-0063,Laser Display Associates Inc. - Approval for Variance,Other,VRA-Approval for Variance,2002-11-08T05:00:00Z,2002,11,,,2008-11-06T13:44:05Z,,0,0,09000064804fc99d
FDA-1993-V-0063-0003,FDA,FDA-1993-V-0063,Laser Display Associates Inc. - Approval for Variance,Other,VRA-Approval for Variance,2002-11-08T05:00:00Z,2002,11,,,2008-11-06T13:42:33Z,,0,0,09000064804fc99c
FDA-2002-E-0525-0003,FDA,FDA-2002-E-0525,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2002-11-05T05:00:00Z,2002,11,,,2008-07-17T19:38:07Z,,0,0,09000064804a5765
FDA-2002-P-0226-0001,FDA,FDA-2002-P-0226,FDA/CFSAN Interim Response to CSPI -  Letter,Other,LET-Letter,2002-11-05T05:00:00Z,2002,11,,,2009-03-18T21:52:38Z,,0,0,090000648049742e
FDA-2002-D-0309-0002,FDA,FDA-2002-D-0309,Draft Guidance for Industry: Regulatory Procedures Manual Chapter 9 Subchapter on Recommending Customs' Seizure and Destruction of Imported Human and Animal Food That Has Not Been ReconditionedDraft Guidance for Industry: Regulatory Procedures Manual Chapter 9 Subchapter on Recommending Customs' Seizure and Destruction of Imported Human and Animal Food That Has Not Been Reconditioned,Other,Guidance,2002-11-04T05:00:00Z,2002,11,2020-09-28T04:00:00Z,,2020-09-28T16:13:25Z,,0,0,090000648049f977
FDA-2002-P-0258-0002,FDA,FDA-2002-P-0258,"FDA/CDER to Lachman Consultant Services,",Other,PAV-Petition Approval,2002-10-21T04:00:00Z,2002,10,,,2008-04-12T01:27:56Z,,0,0,090000648049c4e7
FDA-2001-P-0193-0004,FDA,FDA-2001-P-0193,"FDA/CDER to Mallinckrodt, Inc.",Other,LET-Letter,2002-10-21T04:00:00Z,2002,10,,,2008-04-25T02:27:24Z,,0,0,09000064804e2af1
FDA-2002-P-0129-0002,FDA,FDA-2002-P-0129,"FDA/CDER to Amarin Pharmaceuticals, Inc.",Other,LET-Letter,2002-10-16T04:00:00Z,2002,10,,,2008-04-12T01:26:43Z,,0,0,09000064804905e4
FDA-2002-P-0211-0002,FDA,FDA-2002-P-0211,FDA to University of Colorado Hospit,Other,PAV-Petition Approval,2002-10-16T04:00:00Z,2002,10,,,2008-04-12T01:27:07Z,,0,0,0900006480496792
FDA-2001-P-0191-0003,FDA,FDA-2001-P-0191,"FDA/CDER to Hogan & Hartson, LLP",Other,PAV-Petition Approval,2002-10-16T04:00:00Z,2002,10,,,2008-04-25T02:25:58Z,,0,0,09000064804e2727
FDA-2002-P-0213-0002,FDA,FDA-2002-P-0213,"Letter from FDA CBER to Biogen, Inc.",Other,LET-Letter,2002-10-10T04:00:00Z,2002,10,,,2024-08-13T13:48:09Z,,0,0,0900006480496906
FDA-2002-P-0133-0002,FDA,FDA-2002-P-0133,FDA/CDRH to Hako-Med,Other,PDN-Petition Denial,2002-10-07T04:00:00Z,2002,10,,,2008-04-12T01:26:49Z,,0,0,09000064804909eb
FDA-2001-D-0138-0003,FDA,FDA-2001-D-0138,Exemptions from the Warning Label Requirement for Juice - Recommendations for Effectively Achieving a 5 -Log Pathogen Reduction,Other,Guidance,2002-10-04T04:00:00Z,2002,10,2020-09-28T04:00:00Z,,2024-11-07T21:53:20Z,,1,0,09000064804ddb44
FDA-2002-D-0189-0003,FDA,FDA-2002-D-0189,Guidance for Industry:  Implementation of Section 10809 of the Farm Security and Investment Act of 2002 Regarding the Petition Process to Request Approval of Labeling for Foods that Have Been Treated with Irradiation,Other,Guidance,2002-10-04T04:00:00Z,2002,10,2020-09-28T04:00:00Z,,2024-11-07T21:52:34Z,,1,0,09000064804957e6
FDA-2000-P-1559-0002,FDA,FDA-2000-P-1559,FDA/ORA to CSPI,Other,PDN-Petition Denial,2002-10-02T04:00:00Z,2002,10,,,2008-04-25T01:56:32Z,,0,0,09000064804f9289
FDA-2002-P-0217-0002,FDA,FDA-2002-P-0217,HFD-600 to Lachman Consultant Services,Other,PAV-Petition Approval,2002-10-02T04:00:00Z,2002,10,,,2008-04-12T01:27:13Z,,0,0,0900006480496ca3
FDA-2002-P-0127-0001,FDA,FDA-2002-P-0127,FDA/DDM to Arent Fox Attorneys At Law,Other,ACK-Acknowledgement Letter,2002-10-01T04:00:00Z,2002,10,,,2008-04-12T01:26:40Z,,0,0,0900006480490535
FDA-2002-P-0077-0001,FDA,FDA-2002-P-0077,"FDA/DDM to Highland VetPharma, LLC.",Other,ACK-Acknowledgement Letter,2002-09-30T04:00:00Z,2002,9,,,2008-04-12T01:26:24Z,,0,0,090000648048d2ba
FDA-2002-P-0047-0003,FDA,FDA-2002-P-0047,FDA/CDER to Lavender Consulting Services,Other,PAV-Petition Approval,2002-09-27T04:00:00Z,2002,9,,,2008-04-12T01:26:07Z,,0,0,090000648048b830
FDA-2002-P-0050-0002,FDA,FDA-2002-P-0050,FDA/CDER to SciRegs Consulting,Other,PAV-Petition Approval,2002-09-27T04:00:00Z,2002,9,,,2008-04-12T01:26:10Z,,0,0,090000648048b8a6
FDA-2002-P-0005-0001,FDA,FDA-2002-P-0005,"FDA/DDM to Highland VetPharma, LLC",Other,ACK-Acknowledgement Letter,2002-09-26T04:00:00Z,2002,9,,,2008-04-12T01:25:47Z,,0,0,0900006480487245
FDA-2002-P-0251-0002,FDA,FDA-2002-P-0251,"FDA/CDER to PharmaForce, Inc.",Other,LET-Letter,2002-09-19T04:00:00Z,2002,9,,,2008-04-12T01:27:49Z,,0,0,090000648049be9d
FDA-2002-P-0297-0001,FDA,FDA-2002-P-0297,"FDA/DDM to Highland VetPharma, LLC",Other,ACK-Acknowledgement Letter,2002-09-18T04:00:00Z,2002,9,,,2008-04-12T01:28:08Z,,0,0,090000648049f1dd
FDA-1980-N-0074-0077,FDA,FDA-1980-N-0074,HFD-560 and Consumer Healthcare Prod Assn.,Other,MM-Memorandum of Meeting,2002-09-17T04:00:00Z,2002,9,,,2008-05-30T22:52:25Z,,0,0,09000064805bb535
FDA-2002-P-0007-0001,FDA,FDA-2002-P-0007,Acknowledgement Letter from FDA DMB to the Weinberg Group Inc.,Other,Acknowledgement Letter/Receipt,2002-09-16T04:00:00Z,2002,9,,,2024-09-06T14:52:47Z,,0,0,0900006480487409
FDA-2001-P-0119-0003,FDA,FDA-2001-P-0119,HF-11 to Russell E Dingle,Other,PAV-Petition Approval,2002-09-11T04:00:00Z,2002,9,,,2008-04-25T02:25:02Z,,0,0,09000064804bc584
FDA-2001-P-0119-0004,FDA,FDA-2001-P-0119,HF-11 to Russell E Dingle,Other,PAV-Petition Approval,2002-09-11T04:00:00Z,2002,9,,,2008-04-25T02:25:02Z,,0,0,09000064804bc587
FDA-2001-P-0119-0001,FDA,FDA-2001-P-0119,HF-11 to Russell E Dingle,Other,PAV-Petition Approval,2002-09-11T04:00:00Z,2002,9,,,2008-04-25T02:25:02Z,,0,0,09000064804bc111
FDA-2001-P-0119-0002,FDA,FDA-2001-P-0119,HF-11 to Russell E Dingle,Other,PAV-Petition Approval,2002-09-11T04:00:00Z,2002,9,,,2008-04-25T02:25:04Z,,0,0,09000064804bc581
FDA-2002-P-0170-0001,FDA,FDA-2002-P-0170,FDA/DDM to Intervet Inc.,Other,ACK-Acknowledgement Letter,2002-09-05T04:00:00Z,2002,9,,,2008-04-12T01:26:57Z,,0,0,0900006480494967
FDA-2002-P-0043-0001,FDA,FDA-2002-P-0043,FDA/DDM to Barr Laboratories,Other,ACK-Acknowledgement Letter,2002-09-05T04:00:00Z,2002,9,,,2008-04-12T01:26:03Z,,0,0,090000648048b7b4
FDA-2002-P-0069-0001,FDA,FDA-2002-P-0069,"Acknowledgment Letter from FDA/DMB to Barr Laboratories, Inc.",Other,Acknowledgement Letter/Receipt,2002-09-05T04:00:00Z,2002,9,,,2024-09-06T14:52:11Z,,0,0,090000648048c9f2
FDA-2002-P-0042-0001,FDA,FDA-2002-P-0042,"FDA/DDM to Barr Laboratories, Inc.",Other,ACK-Acknowledgement Letter,2002-09-04T04:00:00Z,2002,9,,,2008-04-12T01:26:02Z,,0,0,090000648048b78e
FDA-2002-P-0259-0001,FDA,FDA-2002-P-0259,FDA/DDM to Taro Research Institute Ltd.,Other,ACK-Acknowledgement Letter,2002-09-04T04:00:00Z,2002,9,,,2008-04-12T01:27:57Z,,0,0,090000648049c53a
FDA-2002-P-0206-0001,FDA,FDA-2002-P-0206,"FDA/DDM to Barr Laboratories, Inc",Other,ACK-Acknowledgement Letter,2002-09-04T04:00:00Z,2002,9,,,2008-04-12T01:27:01Z,,0,0,09000064804961e6
FDA-2001-M-0146-0002,FDA,FDA-2001-M-0146,Petition Denial letter from FDA/CDRH to The TMJ Association,Other,Denial of Petition,2002-08-20T04:00:00Z,2002,8,,,2025-03-06T14:54:59Z,,0,0,09000064804ddc65
FDA-2002-P-0006-0002,FDA,FDA-2002-P-0006,"FDA/CDER to Lachman Consultant Services,",Other,PAV-Petition Approval,2002-08-12T04:00:00Z,2002,8,,,2008-04-12T01:25:47Z,,0,0,0900006480487367
FDA-2002-P-0049-0002,FDA,FDA-2002-P-0049,"HFD-600 to Lachman Consultant Services,",Other,PAV-Petition Approval,2002-08-12T04:00:00Z,2002,8,,,2008-04-12T01:26:09Z,,0,0,090000648048b86b
FDA-2002-P-0293-0001,FDA,FDA-2002-P-0293,FDA/DDM to J. B. Proveedores S.A. DE C.,Other,ACK-Acknowledgement Letter,2002-08-12T04:00:00Z,2002,8,,,2008-04-12T01:28:04Z,,0,0,090000648049f011
FDA-1977-N-0002-0945,FDA,FDA-1977-N-0002,Letter from Gordon Tate re: Comment from The National Grange,Other,Letter(s),2002-08-09T04:00:00Z,2002,8,,,2019-05-09T15:43:48Z,,0,0,09000064805d702a
FDA-2002-P-0173-0001,FDA,FDA-2002-P-0173,FDA/DDM to The Weinberg Group Inc.,Other,ACK-Acknowledgement Letter,2002-08-09T04:00:00Z,2002,8,,,2008-04-12T01:27:00Z,,0,0,0900006480494bf2
FDA-2002-P-0295-0002,FDA,FDA-2002-P-0295,FDA/OC to Society Res Nicotine and Tobacc,Other,LET-Letter,2002-08-08T04:00:00Z,2002,8,,,2008-04-12T01:28:06Z,,0,0,090000648049f159
FDA-2001-P-0189-0002,FDA,FDA-2001-P-0189,FDA/CDER to Abbott Laboratories,Other,PAV-Petition Approval,2002-08-08T04:00:00Z,2002,8,,,2008-04-25T02:27:15Z,,0,0,09000064804e2459
FDA-2020-D-1952-0001,FDA,FDA-2020-D-1952,"CPG Sec. 315.200 Status of Dental Supplies Such as Denture Cleaners Adhesives, Cushions, and Repair Materials as a Device or Cosmetic (CPG REVOKED effective 8/07/2002)",Other,Guidance,2002-08-06T04:00:00Z,2002,8,2020-09-21T04:00:00Z,,2024-11-12T23:24:58Z,,1,0,0900006484868fc6
FDA-2001-P-0155-0004,FDA,FDA-2001-P-0155,"FDA/CDER to Arnall Golden Gregory, LLP",Other,PDN-Petition Denial,2002-08-05T04:00:00Z,2002,8,,,2008-04-25T02:27:48Z,,0,0,09000064804df154
FDA-1978-N-0018-0450,FDA,FDA-1978-N-0018,Acknowledgment Letter from FDA/DDM to Procter & Gamble Company,Other,Acknowledgement Letter/Receipt,2002-07-26T04:00:00Z,2002,7,,,2019-08-06T13:26:48Z,,0,0,090000648055a84c
FDA-1978-N-0018-0451,FDA,FDA-1978-N-0018,"Acknowledgment Letter from FDA/DDM to The Cosmetic, Toiletry & Fragrance Association and The Consumer Healthcare Products Association",Other,Acknowledgement Letter/Receipt,2002-07-26T04:00:00Z,2002,7,,,2019-07-26T15:13:22Z,,0,0,090000648055a84e
FDA-1996-N-0006-0013,FDA,FDA-1996-N-0006,Letter from FDA/CDER to Ciba Specialty Chemicals,Other,Letter(s),2002-07-17T04:00:00Z,2002,7,,,2015-03-19T18:07:53Z,,0,0,09000064804f9976
FDA-2002-P-0247-0001,FDA,FDA-2002-P-0247,Acknowledgement Letter to Mission Possible International,Other,ACK-Acknowledgement Letter,2002-07-16T04:00:00Z,2002,7,,,2009-03-30T14:23:20Z,,0,0,090000648049abb8
FDA-2002-P-0247-0002,FDA,FDA-2002-P-0247,Acknowledgement Letter to Mission Possible International,Other,ACK-Acknowledgement Letter,2002-07-16T04:00:00Z,2002,7,,,2009-03-24T12:05:11Z,,0,0,090000648049ac7e
FDA-2001-P-0056-0004,FDA,FDA-2001-P-0056,"FDA/CDER to Pharmaceutical Associates, Inc.",Other,PDN-Petition Denial,2002-07-12T04:00:00Z,2002,7,,,2008-04-25T01:57:35Z,,0,0,09000064804b7ec9
FDA-1999-P-0126-0007,FDA,FDA-1999-P-0126,FDA/CDER to GlaxoSmithKline,Other,PAV-Petition Approval,2002-07-12T04:00:00Z,2002,7,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9f3
FDA-1999-P-0126-0008,FDA,FDA-1999-P-0126,FDA/CDER to Pharmacia & Upjohn,Other,PAV-Petition Approval,2002-07-12T04:00:00Z,2002,7,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9f5
FDA-2000-P-0153-0002,FDA,FDA-2000-P-0153,"FDA/CDER to Lachman Consultant Services, Inc.",Other,PDN-Petition Denial,2002-07-12T04:00:00Z,2002,7,,,2008-04-25T01:45:52Z,,0,0,09000064804d1424
FDA-2001-P-0055-0002,FDA,FDA-2001-P-0055,"FDA/CDER to Ferndale Laboratories, Inc.",Other,PDN-Petition Denial,2002-07-10T04:00:00Z,2002,7,,,2008-04-25T01:57:35Z,,0,0,09000064804b7ea1
FDA-2001-P-0088-0002,FDA,FDA-2001-P-0088,FDA/CDER to The Weinberg Group Inc.,Other,PDN-Petition Denial,2002-07-10T04:00:00Z,2002,7,,,2008-04-25T02:24:43Z,,0,0,09000064804b866e
FDA-2001-P-0030-0003,FDA,FDA-2001-P-0030,"FDACDER Response to Duramed Pharmaceuticals, Inc. - Petition Approval",Other,PAV-Petition Approval,2002-07-10T04:00:00Z,2002,7,,,2013-07-27T21:00:02Z,,0,0,09000064804b609d
FDA-2000-P-0214-0002,FDA,FDA-2000-P-0214,"FDA/CDER to Lachman Consultant Services,",Other,PAV-Petition Approval,2002-07-10T04:00:00Z,2002,7,,,2008-04-25T01:14:22Z,,0,0,09000064804d4e71
FDA-2002-P-0070-0003,FDA,FDA-2002-P-0070,FDA/DDM to Michael Lisjak,Other,LET-Letter,2002-07-08T04:00:00Z,2002,7,,,2008-04-12T01:26:13Z,,0,0,090000648048cb0b
FDA-2002-P-0003-0003,FDA,FDA-2002-P-0003,FDA/DDM to Johnson & Johnson,Other,ACK-Acknowledgement Letter,2002-07-02T04:00:00Z,2002,7,,,2008-04-12T01:25:45Z,,0,0,09000064804870bf
FDA-2002-P-0291-0004,FDA,FDA-2002-P-0291,FDA/DDM to Ortho-McNeil,Other,ACK-Acknowledgement Letter,2002-07-02T04:00:00Z,2002,7,,,2008-04-12T01:28:02Z,,0,0,090000648049eeef
FDA-1996-N-0006-0005,FDA,FDA-1996-N-0006,Response Letter from FDA/CDER to Buchanan Ingersoll Professional Corporation,Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-03-19T18:40:20Z,,0,0,09000064804f9969
FDA-1996-N-0006-0010,FDA,FDA-1996-N-0006,Letter from FDA/CDER to Ciba Specialty Chemicals,Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-03-20T13:54:01Z,,0,0,09000064804f9973
FDA-1996-N-0006-0009,FDA,FDA-1996-N-0006,Letter from FDA/CDER to Rural Industries Research & Development Corporation,Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-06-19T20:38:35Z,,0,0,09000064804f9972
FDA-1996-N-0006-0007,FDA,FDA-1996-N-0006,"Response from FDA/CDER to Bass & Ullman, P.C.",Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-06-19T20:38:06Z,,0,0,09000064804f996e
FDA-1996-N-0006-0006,FDA,FDA-1996-N-0006,"Response from FDA/CDER to BASF AG [Morgan, Lewis & Bockius, LLP]",Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-03-19T20:19:26Z,,0,0,09000064804f996d
FDA-1996-N-0006-0011,FDA,FDA-1996-N-0006,"Letter from FDA/CDER to EM Industries, Inc.",Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-03-19T17:39:10Z,,0,0,09000064804f9974
FDA-1996-N-0006-0008,FDA,FDA-1996-N-0006,Response from FDA/CDER to The Procter & Gamble Company,Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-03-19T20:35:10Z,,0,0,09000064804f9971
FDA-1996-N-0006-0012,FDA,FDA-1996-N-0006,Letter from FDA/CDER to Covington & Burling,Other,Letter(s),2002-06-26T04:00:00Z,2002,6,,,2015-06-19T20:40:35Z,,0,0,09000064804f9975
FDA-2002-P-0219-0001,FDA,FDA-2002-P-0219,FDA/DDM to King & Spalding,Other,ACK-Acknowledgement Letter,2002-06-25T04:00:00Z,2002,6,,,2008-04-12T01:27:15Z,,0,0,0900006480496e1a
FDA-2020-D-1953-0001,FDA,FDA-2020-D-1953,CPG Sec. 391.100 Advertisement Literature for High-Intensity Mercury Vapor Discharge Lamps - revoked 6/20/02,Other,Guidance,2002-06-20T04:00:00Z,2002,6,2020-09-21T04:00:00Z,,2024-11-06T23:39:05Z,,1,0,0900006484868fc8
FDA-2002-P-0050-0001,FDA,FDA-2002-P-0050,FDA/DDM to SciRegs,Other,ACK-Acknowledgement Letter,2002-06-13T04:00:00Z,2002,6,,,2008-04-12T01:26:10Z,,0,0,090000648048b8a2
FDA-2001-P-0191-0002,FDA,FDA-2001-P-0191,"FDA/CDER to Hogan & Hartson, LLP",Other,LET-Letter,2002-06-12T04:00:00Z,2002,6,,,2008-04-25T02:25:58Z,,0,0,09000064804e2721
FDA-2002-P-0291-0003,FDA,FDA-2002-P-0291,"FDA/CDER to Teva Pharmaceuticals USA, Inc.",Other,PAV-Petition Approval,2002-06-12T04:00:00Z,2002,6,,,2008-04-12T01:28:02Z,,0,0,090000648049eee9
FDA-2002-P-0003-0002,FDA,FDA-2002-P-0003,"FDA/CDER to Caraco Pharms Labs, Ltd.",Other,PAV-Petition Approval,2002-06-12T04:00:00Z,2002,6,,,2008-04-12T01:25:45Z,,0,0,09000064804870b7
FDA-2000-P-0151-0003,FDA,FDA-2000-P-0151,FDA/CFSAN & Sartori Food Corp.,Other,MT-Memorandum of Telephone Conversation,2002-06-11T04:00:00Z,2002,6,,,2008-04-25T01:31:51Z,,0,0,09000064804d1180
FDA-2002-P-0211-0001,FDA,FDA-2002-P-0211,FDA/DDM to University of Colorado Hospital,Other,ACK-Acknowledgement Letter,2002-06-04T04:00:00Z,2002,6,,,2008-04-12T01:27:07Z,,0,0,0900006480496755
FDA-1980-N-0036-0012,FDA,FDA-1980-N-0036,FDA/Office of the Commissioner to The Purdue Fredrick Company,Other,LET-Letter,2002-05-31T04:00:00Z,2002,5,,,2008-12-05T14:27:46Z,,0,0,09000064805b948c
FDA-2002-P-0003-0001,FDA,FDA-2002-P-0003,FDA/DDM to Winston & Strawn,Other,ACK-Acknowledgement Letter,2002-05-31T04:00:00Z,2002,5,,,2008-04-12T01:25:45Z,,0,0,090000648048707d
FDA-2002-P-0166-0001,FDA,FDA-2002-P-0166,FDA/DDM to AAC Consulting Group,Other,ACK-Acknowledgement Letter,2002-05-30T04:00:00Z,2002,5,,,2008-04-12T01:26:53Z,,0,0,09000064804945ae
FDA-1995-P-0044-0002,FDA,FDA-1995-P-0044,"FDA/CDER to Westwood Squibb Pharms, Inc.",Other,CR-Correction,2002-05-24T04:00:00Z,2002,5,,,2008-05-16T23:07:31Z,,0,0,090000648056143c
FDA-2001-P-0216-0003,FDA,FDA-2001-P-0216,FDA/CDER to Pharmacia Consumer Healthcare I,Other,PAV-Petition Approval,2002-05-16T04:00:00Z,2002,5,,,2008-04-25T02:38:56Z,,0,0,09000064804e4a2a